FONAR (FONR) Competitors $14.57 -0.37 (-2.48%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$14.61 +0.04 (+0.27%) As of 03/3/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends FONR vs. ZIMV, NYXH, LUNG, TCMD, NNOX, CVRX, SMTI, AVR, RCEL, and ZYXIShould you be buying FONAR stock or one of its competitors? The main competitors of FONAR include ZimVie (ZIMV), Nyxoah (NYXH), Pulmonx (LUNG), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), CVRx (CVRX), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), AVITA Medical (RCEL), and Zynex (ZYXI). These companies are all part of the "medical equipment" industry. FONAR vs. ZimVie Nyxoah Pulmonx Tactile Systems Technology Nano-X Imaging CVRx Sanara MedTech Anteris Technologies Global AVITA Medical Zynex ZimVie (NASDAQ:ZIMV) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Which has more volatility and risk, ZIMV or FONR? ZimVie has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Does the MarketBeat Community prefer ZIMV or FONR? FONAR received 176 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 23.53% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformZimVieOutperform Votes423.53% Underperform Votes1376.47% FONAROutperform Votes18074.69% Underperform Votes6125.31% Is ZIMV or FONR more profitable? FONAR has a net margin of 7.68% compared to ZimVie's net margin of -77.31%. FONAR's return on equity of 4.94% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets ZimVie-77.31% 2.90% 1.17% FONAR 7.68%4.94%3.70% Which has preferable valuation & earnings, ZIMV or FONR? FONAR has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimVie$449.75M0.83-$393.28M-$0.95-14.19FONAR$101.57M0.89$10.57M$1.1512.67 Does the media refer more to ZIMV or FONR? In the previous week, ZimVie had 13 more articles in the media than FONAR. MarketBeat recorded 14 mentions for ZimVie and 1 mentions for FONAR. FONAR's average media sentiment score of 1.87 beat ZimVie's score of 0.41 indicating that FONAR is being referred to more favorably in the news media. Company Overall Sentiment ZimVie Neutral FONAR Very Positive Do insiders & institutionals believe in ZIMV or FONR? 95.6% of ZimVie shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 3.0% of ZimVie shares are held by insiders. Comparatively, 2.2% of FONAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate ZIMV or FONR? ZimVie presently has a consensus target price of $19.50, indicating a potential upside of 44.66%. Given ZimVie's stronger consensus rating and higher probable upside, analysts clearly believe ZimVie is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZimVie 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryFONAR beats ZimVie on 10 of the 18 factors compared between the two stocks. Get FONAR News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFONARElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$90.38M$3.48B$5.81B$8.39BDividend YieldN/A1.62%4.75%3.98%P/E Ratio12.6717.1024.9519.21Price / Sales0.8958.22375.54110.22Price / Cash4.7844.0938.0534.58Price / Book0.573.667.334.28Net Income$10.57M$94.03M$3.18B$247.04M7 Day Performance-1.95%-4.75%-4.42%-4.36%1 Month Performance-6.18%0.34%-6.07%-5.59%1 Year Performance-35.24%1.39%11.42%3.39% FONAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFONAR1.934 of 5 stars$14.57-2.5%N/A-35.2%$90.38M$101.57M12.67480ZIMVZimVie2.3758 of 5 stars$13.32+0.1%$19.50+46.4%-20.4%$367.63M$457.43M-1.022,600Earnings ReportNYXHNyxoah2.2898 of 5 stars$10.36+0.1%$17.00+64.1%-32.9%$352.86M$4.70M-5.54110News CoverageLUNGPulmonx3.3389 of 5 stars$8.92-0.4%$12.75+42.9%-10.9%$352.25M$83.79M-6.19250News CoverageGap DownTCMDTactile Systems Technology3.2259 of 5 stars$14.90-1.0%$18.00+20.8%-8.2%$351.42M$292.98M21.29980Short Interest ↑NNOXNano-X Imaging1.771 of 5 stars$6.02-4.4%$17.50+190.7%-48.7%$347.84M$9.90M-7.08190CVRXCVRx2.366 of 5 stars$13.16-5.0%$17.83+35.5%-40.6%$342.69M$51.29M-4.89160SMTISanara MedTech2.6639 of 5 stars$35.39+5.0%$47.00+32.8%-15.8%$309.31M$64.99M-35.7560News CoverageAVRAnteris Technologies GlobalN/A$7.27-11.9%$16.50+127.0%N/A$261.28M$2.71M0.00138RCELAVITA Medical1.5199 of 5 stars$9.41-3.5%$17.25+83.3%-51.7%$255.63M$64.25M-3.94130ZYXIZynex3.4414 of 5 stars$7.36+2.4%$14.00+90.2%-41.4%$234.42M$184.32M49.071,100 Related Companies and Tools Related Companies ZimVie Competitors Nyxoah Competitors Pulmonx Competitors Tactile Systems Technology Competitors Nano-X Imaging Competitors CVRx Competitors Sanara MedTech Competitors Anteris Technologies Global Competitors AVITA Medical Competitors Zynex Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FONR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FONAR Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share FONAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.